Be sure to check our sister interview main ratings news website

ARIX

Hardman & Co

Arix Bioscience: Multiple inflection points in 2020

28th February 2020

Arix Bioscience plc (LON:ARIX) is the topic of conversation when Dr Dorothea Hill, Analyst at Hardman & Co joins DirectorsTalk. Having recently initiated on Arix Bioscience Dorothea explains the key takeaways

Hardman & Co

Arix Bioscience With high risk can come high reward

19th February 2020

Arix Bioscience (Arix) is a listed global venture capital (VC) company that presents an opportunity for institutional and retail investors to participate in the high risk-return profile of early-stage biotech

Interviews

Arbuthnot Banking Group 2023 results, strategic choices paying dividends (VIDEO)
Arbuthnot Banking Group 2023 results, strategic choices paying dividends...
Mark highlights the bank’s successful...
Valeura Energy Strategic Acquisitions and Successful Exploration Boosting Shares and Reserves
Valeura Energy Strategic Acquisitions and Successful Exploration Boosting Shares...
Valeura Energy Inc. (TSX:VLE) is the...
Team Plc Positive Q1 and Strategic Outlook for 2024 with Craig Farley (VIDEO)
Team Plc Positive Q1 and Strategic Outlook for 2024...
TEAM Plc (LON:TEAM) Head of Multi-Asset...
Gattaca Plc on Path for Sustainable Growth after Resilient Performance and Strategic Adjustments (VIDEO)
Gattaca Plc on Path for Sustainable Growth after Resilient...
Gattaca plc (LON:GATC) CEO Matthew Wragg,...
Valeura Energy’s Strategic Surge in Thailand’s Oil Industry (VIDEO)
Valeura Energy’s Strategic Surge in Thailand’s Oil Industry (VIDEO)
Valeura Energy (TSX:VLE) have today published...

Funds

Why invest in Fidelity Emerging Markets? Q&A with Heather Manners FEML Chair
Why invest in Fidelity Emerging Markets? Q&A with Heather Manners FEML Chair
Stability and Performance of European CLOs
Stability and Performance of European CLOs
TEAM plc Chief Investment Officer on Q1 Performance Drivers & Strategy
TEAM plc Chief Investment Officer on Q1 Performance Drivers & Strategy
Investing in BRICS: Understanding the Emerging Market powerhouses
Investing in BRICS: Understanding the Emerging Market powerhouses
FTSE 100 hits Record High on weaker pound and Positive Updates
FTSE 100 hits Record High on weaker pound and Positive Updates
Benefits of saving money early in life
Benefits of saving money early in life

Presentations

Time Finance Plc Q3 Results and Profit Upgrades with Ed Rimmer CEO (VIDEO)
Time Finance Plc Q3 Results and Profit Upgrades with...
Time Finance Plc (LON:TIME) CEO Ed...
Poolbeg Pharma A Strategic Vision, Pioneering the Future of Innovative Medicine
Poolbeg Pharma A Strategic Vision, Pioneering the Future of...
A Poolbeg Pharma Plc (LON:POLB) Investor Presentation...
Cerillion plc Overview and Annual Results by CEO & CFO
Cerillion plc Overview and Annual Results by CEO &...
Cerillion plc (LON:CER) Overview and Annual...
Likewise Group Tony Brewer: Capturing beyond 10% of £2 billion flooring market (Video)
Likewise Group Tony Brewer: Capturing beyond 10% of £2...
Likewise Group plc (LON:LIKE) CEO Tony...
East Imperial Plc 2023 interims and strategic plans by Tony Burt, CEO
East Imperial Plc 2023 interims and strategic plans by...
East Imperial Plc (LON:EISB) CEO and...

Broker Talk

Chesnara Plc 2023 results show Positive Returns, Dividend Increase, and Undervalued Stock
Chesnara Plc 2023 results show Positive Returns, Dividend Increase, and Undervalued Stock
Tissue Regenix Group: Profitable and Cash-Generating Growth Strategy 2024
Tissue Regenix Group: Profitable and Cash-Generating Growth Strategy 2024
NB Private Equity Partners Ltd: Value creation evolution and investment summary
NB Private Equity Partners Ltd: Value creation evolution and investment summary
RECI – Hardman research underlines its strong liquidity and portfolio resilience, Feb 2024
RECI – Hardman research underlines its strong liquidity and portfolio resilience, Feb 2024
City of London Investment Group reports strong growth and cost reductions in Q2 2024
City of London Investment Group reports strong growth and cost reductions in Q2 2024
Accrol Group: strong margins and volume growth continues into H2, says Shore Capital
Accrol Group: strong margins and volume growth continues into H2, says Shore Capital

© 2023 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.